Nutcracker Therapeutics Inc logo
Healthcare & Life Sciences

Nutcracker Therapeutics Inc

United Stateswww.businesswire.com/news/home/20220314005099/en/Nutcracker-Therapeutics-Raises-167-Million-in-Series-C-Financing-to-Advance-its-mRNA-Therapeutics-and-First-of-its-Kind-Biochip-based-Manufacturing-Platform

Nutcracker Therapeutics Inc is a series c plus startup based in United States. 1 investor tracked.

Activeseries-c-plus
View Full ProfileWebsite
series-c-plus
Stage
2018
Founded
1
Investors

About Nutcracker Therapeutics Inc

Based in the United States, Nutcracker Therapeutics Inc is a startup founded in 2018. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

The biotech firm is developing cancer treatments using ribonucleic acid (mRNA) therapy.

Explore Nutcracker Therapeutics Inc's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

View Startup Profile →View pricing

Other Startups in United States

Nutcracker Therapeuticsseries-c-plusNuSpeedNuSkool SnacksNUSICNuscript RXseries-aNuscript RXNutcrackerxNu-Tek BiosciencesNuTEQ SolutionsNuTera Safety SolutionsNutilitiAllMade Materials